51 Biggest Movers From Yesterday

Gainers

  • Amarin Corporation plc AMRN shares surged 314.72 percent to close at $12.40 on Monday after the company's REDUCE-IT cardiovascular study of Vascepa in LDL-C patients met its primary endpoint.
  • SAExploration Holdings, Inc. SAEX shares jumped 284.34 percent to close at $28.71.
  • Jones Energy, Inc. JONE gained 36.12 percent to close at $6.52. Jones Energy regained compliance with NYSE continued listing requirements.
  • Intrexon Corporation XON gained 31.52 percent to close at $19.07 after announcing advances in development of its microbial platform to produce cannabinoids for medical uses.
  • Apollo Medical Holdings, Inc. AMEH gained 18.66 percent to close at $19.71.
  • Akcea Therapeutics, Inc. AKCA climbed 18.23 percent to close at $33.08 after the company earlier reported data from a Phase 2 study of AKCEA-APO(a)-LRx in patients with cardiovascular disease.
  • California Resources Corporation CRC shares gained 17.63 percent to close at $46.58.
  • AcelRx Pharmaceuticals, Inc. ACRX rose 16.46 percent to close at $4.60.
  • Mexco Energy Corporation MXC gained 15.82 percent to close at $5.71 on Monday.
  • Achieve Life Sciences, Inc. ACHV shares rose 15.66 percent to close at $2.88.
  • LiveXLive Media, Inc. LIVX gained 15.38 percent to close at $4.05.
  • Innovate Biopharmaceuticals, Inc. INNT shares rose 14.7 percent to close at $7.96.
  • Seabridge Gold Inc. SA shares climbed 14.16 percent to close at $12.90.
  • Conatus Pharmaceuticals Inc. CNAT gained 13.66 percent to close at $6.49.
  • Applied Genetic Technologies Corporation AGTC climbed 13.64 percent to close at $5.00. Wells Fargo upgraded Applied Genetic Technologies from Market Perform to Outperform.
  • Geron Corporation GERN gained 13.55 percent to close at $6.20.
  • Adamis Pharmaceuticals Corporation ADMP shares rose 12.9 percent to close at $3.50.
  • Idera Pharmaceuticals, Inc. IDRA gained 12.78 percent to close at $9.53. Barclays initiated coverage on Idera Pharmaceuticals with an Overweight rating.
  • Medigus Ltd. MDGS surged 12.7 percent to close at $3.55.
  • Y-mAbs Therapeutics, Inc. YMAB gained 12.37 percent to close at $26.97.
  • Fate Therapeutics, Inc. FATE rose 11.74 percent to close at $16.28.
  • AzurRx BioPharma Inc AZRX rose 11.32 percent to close at $2.95 after the company's Phase IIa trial of MS1819-SD for exocrine pancreatic insufficiency met its primary endpoints.
  • AnaptysBio, Inc. ANAB rose 9.86 percent to close at $101.95. AnaptysBio reported 'positive' topline data from Phase 2a proof-of-concept clinical trial of etokimab in severe eosinophilic asthma.
  • Xenetic Biosciences, Inc. XBIO shares rose 9.31 percent to close at $3.64.
  • EP Energy Corporation EPE gained 8.7 percent to close at $2.25.
  • Aridis Pharmaceuticals, Inc. ARDS shares rose 7.99 percent to close at $12.97 after the company reported patent issuance covering two product candidates, AR-201 and AR-401.
  • ENDRA Life Sciences Inc. NDRA shares rose 7.85 percent to close at $3.57.
  • Immutep Limited IMMP rose 6.98 percent to close at $3.22 after announcing a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.
  • Randgold Resources Limited GOLD rose 6.62 percent to close at $68.14 after the company announced plans to merge with Barrick Gold Corp ABX in a deal worth $18.3 billion.
  • Alexion Pharmaceuticals, Inc. ALXN shares gained 5.34 percent to close at $128.51 after the company disclosed that Phase 3 study of soliris met its primary endpoint.

 


Losers

  • Altimmune, Inc. ALT dipped 46.93 percent to close at $13.90 on Monday. Altimunne reported a $4.9 million common stock offering. Altimmune reported that it has been awarded additional $2.5 million in BARDA funding to support nasoshield development.
  • Astrotech Corporation ASTC fell 40.43 percent to close at $3.33. Astrotech posted a Q4 loss of $0.63 per share on sales of $45,000.
  • Cool Holdings, Inc. AWSM shares dropped 36.37 percent to close at $12.09 on Monday after surging 80.95 percent on Friday.
  • New Age Beverages Corporation NBEV shares dropped 35.61 percent to close at $3.96 after reporting a $50 million at-the-market offering.
  • Spectrum Pharmaceuticals, Inc. SPPI dipped 22.66 percent to close at $16.52. Spectrum Pharmaceuticals disclosed release of updated poziotinib data from MD Anderson Phase 2 study in non-small cell lung cancer patients.
  • Tilray, Inc. TLRY shares declined 19.11 percent to close at $99.50 after dropping 30.25 percent on Friday.
  • Nightstar Therapeutics plc NITE dropped 16.43 percent to close at $21.31.
  • Qutoutiao Inc. QTT shares fell 15.07 percent to close at $7.27.
  • Therapix Biosciences Ltd. TRPX dipped 14.29 percent to close at $4.50.
  • Surface Oncology, Inc. SURF shares fell 13.24 percent to close at $10.42.
  • JAKKS Pacific, Inc. JAKK shares dropped 12.07 percent to close at $2.55.
  • Leju Holdings Limited LEJU shares fell 11.47 percent to close at $1.93 on Monday.
  • Reed's, Inc. REED shares dropped 11.11 percent to close at $3.20.
  • Rosehill Resources Inc. ROSE tumbled 10.56 percent to close at $7.20 after reporting a 6.15 million share offering.
  • India Globalization Capital, Inc. IGC fell 10.34 percent to close at $2.60 on Monday after rising 34.88 percent on Friday. India Globalization Capital filed prospectus for sale of up to $20 million in common stock, warrants and units.
  • PPDAI Group Inc. PPDF fell 9.24 percent to close at $5.99.
  • Aurora Mobile Limited JG shares dipped 8.74 percent to close at $7.52.
  • Nutanix, Inc. NTNX declined 8.72 percent to close at $42.40. Susquehanna downgraded Nutanix from Neutral to Negative.
  • Chuy's Holdings, Inc. CHUY dipped 8.24 percent to close at $25.05. BMO Capital downgraded Chuy's from Market Perform to Underperform and lowered the price target from $28 to $23.
  • Michael Kors Holdings Limited KORS dropped 8.23 percent to close at $66.71 following earlier reports the company is nearing a deal to acquire Versace for $2 billion.
  • Comcast Corporation CMCSA dropped 5.99 percent to close at $35.63 following the company's $39 billion offer for Sky. Analysts at Oppenheimer And Moffett Nathanson downgraded the stock.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMoversTrading IdeasFinancialsInvestment Banking & BrokerageLosersMovers From YesterdayTop GainersYesterday's Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!